Journal article
Economic evaluation of intravenous immune globulin therapy for Kawasaki syndrome
Abstract
OBJECTIVE: To determine the costs and clinical outcomes of three alternative treatments of the acute phase of Kawasaki syndrome: aspirin alone; low doses of intravenously administered immune globulin (IVIG-LD), 400 mg/kg per dose for 4 days; and high doses of intravenously administered immune globulin (IVIG-HD), 2.0 gm/kg for one dose.
DESIGN: A model was developed that assumed the inclusion of 100 patients with acute Kawasaki syndrome in each …
Authors
Klassen TP; Rowe PC; Gafni A
Journal
The Journal of Pediatrics, Vol. 122, No. 4, pp. 538–542
Publisher
Elsevier
Publication Date
April 1993
DOI
10.1016/s0022-3476(05)83532-2
ISSN
0022-3476